ASX 200 Outlook: CSL, COH, Drag Healthcare and ASX Lower

The ASX 200 has slipped into a more defensive tone, with healthcare stocks driving a sharp selloff despite an extension to the Iran ceasefire. A steep decline in Cochlear (COH) weighed heavily on the broader index, raising questions about whether the market is entering a deeper pullback or simply pausing before its next move higher.

 

View related analysis:

• Nikkei 225 Eyes Record High as Bullish Exposure Builds - But Headwinds Emerge
• Gold Loses Safe-Haven Appeal as Iran Skips Talks, Ceasefire Extended
• ASX 200 Outlook: Consumer Stocks Lead, ASX Eyes 9000 Breakout
• AUD/USD Outlook: Pullback Below 0.72 Underway as Geopolitical Risks Intensify

 

 

ASX 200 Outlook: CSL, COH Drag Healthcare and ASX Lower

ASX 200 Market Snapshot

• The ASX 200 fell -1.2% on Wednesday, despite the US announcing an indefinite extension to the Iran ceasefire
• The day’s range of 1.25% marked its most volatile session in two weeks, pushing the index into a clearer corrective phase
• Healthcare (XHJ) led seven sectors lower, falling -6% in its worst session since October. Cochlear (COH) plunged -40.7%, Global Health (GLH) fell -12.8%, and CSL (CSL) declined -5.7%
• Financials (XFJ) also fell -2.2%, with CBA (CBA) down -2.5%, leading the Big Four lower
• Consumer staples (XSJ) rallied for a third consecutive session, closing at their highest level since August 2023, with Woolworths (WOW) and Coles (COL) rising 0.9% and 0.4% respectively
• Volatility typically eases into the end of the week, based on 3-month and 1-year averages

 

Source: ASX, LSEG

 

 

Healthcare Sector Breaks Down as Selling Accelerates

The ASX healthcare sector (XHJ) has taken a decisive turn lower, breaking down from a bear flag pattern within an established downtrend — a classic continuation signal. The move has been led by Cochlear (COH), which plunged more than 40% in a single session, dragging the broader sector sharply lower. Relative performance has also deteriorated against the wider market, highlighting clear capital rotation away from healthcare.

Ultimately, this looks like a bearish trend breakdown, and rallies in names such as CSL (CSL) and Ramsay Health Care (RHC) may continue to be sold unless the sector can reclaim key support levels.

Source: ASX, LSEG

 

 

ASX 200 Technical Analysis

ASX 200 Range Holds as 9000 Caps Upside and 8900 Acts as Key Pivot

Options positioning shows the ASX 200 remains within a defined trading range, with key levels clustering around current price. The 8900 area is the main battleground, where price may continue to consolidate. Above, 8950–9000 forms a resistance zone, where rallies are likely to slow. On the downside, 8800 provides initial support, with 8700 acting as a stronger floor if selling pressure builds.

In a nutshell: Expect range-bound conditions, with chop around 8900, resistance near 9000, and support layered below 8800.

 

Momentum Turns Lower as 8900 Resistance Caps Near-Term Upside

The daily chart shows momentum has turned against the prior rally, following a tight consolidation near cycle highs. The 50-day EMA sits around 8800, making it a viable near-term downside target for bears.

However, SPI 200 (ASX 200) futures attempted to build support above the March 11 high and weekly S2 pivot point overnight, leaving scope for a near-term bounce. That said, resistance around weekly S1 pivot and 8900–8923 zone may attract sellers, particularly as it sits well below the weekly VWAP, which is now curling lower.

Source: ASX, TradingView

 

 

View the full economic calendar

 

-- Written by Matt Simpson

Follow Matt on Twitter @cLeverEdge